garajstock / Shutterstock.com
25 April 2016Americas
Global biotech associations back Sequenom in Ariosa row
A group of biotechnology industry associations has stepped into the Ariosa v Sequenom dispute, which may be reviewed by the US Supreme Court.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Americas
22 March 2016 Sequenom has urged the US Supreme Court to hear its patent dispute with Ariosa Diagnostics.
Americas
3 December 2015 There were no surprises, but plenty of alarms yesterday following the US Court of Appeals for the Federal Circuit’s decision to reject Sequenom’s request for a re-hearing of its dispute with Ariosa Diagnostics en banc.
Editor's picks
Editor's picks
Americas
22 March 2016 Sequenom has urged the US Supreme Court to hear its patent dispute with Ariosa Diagnostics.
Americas
3 December 2015 There were no surprises, but plenty of alarms yesterday following the US Court of Appeals for the Federal Circuit’s decision to reject Sequenom’s request for a re-hearing of its dispute with Ariosa Diagnostics en banc.
Americas
22 March 2016 Sequenom has urged the US Supreme Court to hear its patent dispute with Ariosa Diagnostics.
Americas
3 December 2015 There were no surprises, but plenty of alarms yesterday following the US Court of Appeals for the Federal Circuit’s decision to reject Sequenom’s request for a re-hearing of its dispute with Ariosa Diagnostics en banc.